The Discounted Cash Flow (DCF) valuation of Myriad Genetics Inc (MYGN) is (43.53) USD. With the latest stock price at 14.43 USD, the upside of Myriad Genetics Inc based on DCF is -401.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.0% - 10.2% | 8.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (97.20) - (28.67) | (43.53) |
| Upside | -773.6% - -298.7% | -401.7% |